Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.73 (
urokinase-type plasminogen activator
)
10,685
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cyr61
is a heparin-binding, extracellular matrix-associated protein of the CCN family, which also includes connective tissue growth factor, Nov, WISP-1, WISP-2, and WISP-3.
Cyr61
is capable of multiple functions, including induction of angiogenesis in vivo. Purified
Cyr61
mediates cell adhesion and induces adhesive signaling, stimulates cell migration, enhances cell proliferation, and promotes cell survival in both fibroblasts and endothelial cells. In this study, we have used cDNA array hybridization to identify genes regulated by
Cyr61
in primary human skin fibroblasts. The
Cyr61
-regulated genes fall into several groups known to participate in processes important for cutaneous wound healing, including: 1) angiogenesis and lymphogenesis (VEGF-A and VEGF-C); 2) inflammation (interleukin-1beta); 3) extracellular matrix remodeling (MMP1, MMP3, TIMP1,
uPA
, and PAI-1); and 4) cell-matrix interactions (Col1alpha1, Col1alpha2, and integrins alpha(3) and alpha(5)).
Cyr61
-mediated gene expression requires heparin binding activity of
Cyr61
, cellular de novo transcription, and protein synthesis and is largely dependent on the activation of p42/p44 MAPKs.
Cyr61
regulates gene expression not only in serum-free medium but also in fibroblasts cultured on various matrix proteins or in the presence of 10% serum. These effects of
Cyr61
can be sustained for at least 5 days, consistent with the time course of wound healing in vivo. Interestingly,
Cyr61
can interact with transforming growth factor-beta1 to regulate expression of specific genes in an antagonistic, additive, or synergistic manner. Furthermore, we show that the
Cyr61
gene is highly induced in dermal fibroblasts of granulation tissue during cutaneous wound repair. Together, these results show that
Cyr61
is inducibly expressed in granulation tissues after wounding and that
Cyr61
activates a genetic program for wound repair in skin fibroblasts. We propose a model in which
Cyr61
integrates its activities on endothelial cells, fibroblasts, and macrophages to regulate the processes of angiogenesis, inflammation, and matrix remodeling in the context of cutaneous wound healing.
...
PMID:The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. 1158 15
Glioblastoma multiforme (GBM) is an aggressively invasive brain neoplasm with poor patient prognosis. We have previously shown that the bioactive lipid sphingosine-1-phosphate (S1P) stimulates in vitro invasiveness of GBM cells and that high expression levels of the enzyme that forms S1P, sphingosine kinase-1 (SphK1), correlate with shorter survival time of GBM patients. We also recently showed that S1P induces expression of CCN1 (also known as
Cyr61
), a matricellular protein known to correlate with poor patient prognosis, in GBM cells. In this study, we further explored the role of CCN1 as well as the
urokinase plasminogen activator
(
uPA
), a protein known to stimulate GBM cell invasiveness, in S1P-induced invasion using a spheroid invasion assay. We also investigated the roles of various S1P receptors in stimulating invasiveness through these pathways. S1P induced expression of
uPA
and its receptor, uPAR, in GBM cells. Whereas S1P(1), S1P(2), and S1P(3) receptors all contribute, at least partially, S1P(1) overexpression led to the most dramatic induction of the
uPA
system and of spheroid invasion, even in the absence of added S1P. Furthermore, neutralizing antibodies directed against
uPA
or CCN1 significantly decreased both basal and S1P-stimulated GBM cell invasiveness. Inhibition of SphK blocked basal expression of
uPA
and uPAR, as well as glioma cell invasion; however, overexpression of SphK did not augment S1P receptor-mediated enhancement of
uPA
activity or invasion. Thus, SphK is necessary for basal activity of the
uPA
system and glioma cell invasion, whereas S1P receptor signaling enhances invasion, partially through
uPA
and CCN1.
...
PMID:Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. 1914 34